SQL | SeqLL Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	6.60 - 8.20
52 Week Range	6.60 - 8.20
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	19,321
Average Volume	N/A
Shares Outstanding	N/A
Market Cap	2,573,180
Sector	Healthcare
Industry	Medical - Diagnostics & Research
IPO Date	2021-08-27

Valuation
Profitability
Growth
Health
P/E Ratio	-0.40
Forward P/E Ratio	N/A
EPS	-16.40
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	7
Country	USA
Website	SQL

SeqLL Inc is a life science instrumentation and services company. Its True Single Molecule Sequencing platform offers a single molecule solution for DNA and RNA sequencing by performing the detection of nucleic acids. The data produced by the platform generates molecular profiles, providing researchers with new insights into biology.

SQL's peers: EZFL, GENE, ISPC, ME, NDRA, TTOO, UNCY, BIAF

*Chart delayed

Analyzing fundamentals for SQL we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see SQL Fundamentals page.

Watching at SQL technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on SQL Technicals page.